Emerging science of hydroxyurea therapy for pediatric sickle cell disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging science of hydroxyurea therapy for pediatric sickle cell disease
Authors
Keywords
-
Journal
PEDIATRIC RESEARCH
Volume 75, Issue 1-2, Pages 196-204
Publisher
Springer Nature
Online
2013-11-20
DOI
10.1038/pr.2013.227
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Systematic Review of Barriers and Interventions to Improve Appropriate Use of Therapies for Sickle Cell Disease
- (2016) Carlton Haywood et al. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
- Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: Results from the SWiTCH clinical trial
- (2013) Ofelia Alvarez et al. AMERICAN JOURNAL OF HEMATOLOGY
- Systematic Review: Hydroxyurea for the Treatment of Adults with Sickle Cell Disease
- (2013) Sophie Lanzkron et al. ANNALS OF INTERNAL MEDICINE
- The effect of hydroxcarbamide therapy on survival of children with sickle cell disease
- (2013) Clarisse Lopes de Castro Lobo et al. BRITISH JOURNAL OF HAEMATOLOGY
- Fetal hemoglobin and hydroxycarbamide moduate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children
- (2013) D. Nebor et al. HAEMATOLOGICA
- Sickle cell disease related mortality in the United States (1999-2009)
- (2013) Dima Hamideh et al. PEDIATRIC BLOOD & CANCER
- Candidate Sequence Variants and Fetal Hemoglobin in Children with Sickle Cell Disease Treated with Hydroxyurea
- (2013) Nancy S. Green et al. PLoS One
- Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia
- (2012) Banu Aygun et al. AMERICAN JOURNAL OF HEMATOLOGY
- Antisickling fetal hemoglobin reduces hypoxia-inducible factor-1α expression in normoxic sickle mice: microvascular implications
- (2012) Dhananjay K. Kaul et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Stem Cell Transplant for Children with Sickle Cell Anemia: Parent and Patient Interest
- (2012) Michael Roth et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impact of hydroxyurea on clinical events in the BABY HUG trial
- (2012) C. D. Thornburg et al. BLOOD
- Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice
- (2012) C. B. Almeida et al. BLOOD
- Stroke With Transfusions Changing to Hydroxyurea (SWiTCH)
- (2012) R. E. Ware et al. BLOOD
- Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans
- (2012) H. T. Bae et al. BLOOD
- Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia
- (2012) Jonathan M. Flanagan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease
- (2012) Suzette O. Oyeku et al. PEDIATRIC BLOOD & CANCER
- Hydroxyurea for the treatment of sickle cell disease: Efficacy, barriers, toxicity, and management in children
- (2012) John J. Strouse et al. PEDIATRIC BLOOD & CANCER
- Effect of hydroxyurea treatment on renal function parameters: Results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia
- (2012) Ofelia Alvarez et al. PEDIATRIC BLOOD & CANCER
- Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia
- (2011) R. E. Ware et al. BLOOD
- Hydroxyurea therapy of a murine model of sickle cell anemia inhibits the progression of pneumococcal disease by down-modulating E-selectin
- (2011) J. D. Lebensburger et al. BLOOD
- Epigenetic and molecular profiles of erythroid cells after hydroxyurea treatment in sickle cell anemia
- (2011) A. L. Walker et al. BLOOD
- Ancestry of African Americans with sickle cell disease
- (2011) Nadia Solovieff et al. BLOOD CELLS MOLECULES AND DISEASES
- Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain?
- (2011) Patrick T McGann et al. CURRENT OPINION IN HEMATOLOGY
- In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology
- (2011) Michelle Tsai et al. JOURNAL OF CLINICAL INVESTIGATION
- Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients
- (2011) Pallav Bhatnagar et al. JOURNAL OF HUMAN GENETICS
- Differences in Health-Related Quality of Life in Children With Sickle Cell Disease Receiving Hydroxyurea
- (2011) Courtney D. Thornburg et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)
- (2011) Winfred C Wang et al. LANCET
- Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease
- (2010) Sean D. Candrilli et al. AMERICAN JOURNAL OF HEMATOLOGY
- Population Estimates of Sickle Cell Disease in the U.S.
- (2010) Kathryn L. Hassell AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia
- (2010) J. Makani et al. BLOOD
- Pulmonary hypertension and nitric oxide depletion in sickle cell disease
- (2010) H. F. Bunn et al. BLOOD
- Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort
- (2010) F. Bernaudin et al. BLOOD
- Improved survival of children and adolescents with sickle cell disease
- (2010) C. T. Quinn et al. BLOOD
- Update on fetal hemoglobin gene regulation in hemoglobinopathies
- (2010) Daniel E Bauer et al. CURRENT OPINION IN PEDIATRICS
- Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model
- (2010) J. D. Lebensburger et al. HAEMATOLOGICA
- Assessment of genotoxicity associated with hydroxyurea therapy in children with sickle cell anemia
- (2010) Jonathan M. Flanagan et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation
- (2010) Geneviève Galarneau et al. NATURE GENETICS
- Expression patterns of fetal hemoglobin in sickle cell erythrocytes are both patient- and treatment-specific during childhood
- (2010) Emily Riehm Meier et al. PEDIATRIC BLOOD & CANCER
- Health-related quality of life in children with sickle cell disease: A report from the Comprehensive Sickle Cell Centers Clinical Trial Consortium
- (2010) Carlton Dampier et al. PEDIATRIC BLOOD & CANCER
- Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions
- (2009) Gregory J. Kato et al. AMERICAN JOURNAL OF HEMATOLOGY
- The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)
- (2009) E. Voskaridou et al. BLOOD
- Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster
- (2009) N. Solovieff et al. BLOOD
- Discovering the genetics underlying foetal haemoglobin production in adults
- (2009) Swee Lay Thein et al. BRITISH JOURNAL OF HAEMATOLOGY
- Nonoptimal Microbial Response to Antibiotics Underlies Suppressive Drug Interactions
- (2009) Tobias Bollenbach et al. CELL
- Hydroxyurea Generates Nitric Oxide in Human Erythroid Cells: Mechanisms for γ-Globin Gene Activation
- (2009) Tzu-Fang Lou et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- BCL11A is a major HbF quantitative trait locus in three different populations with β-hemoglobinopathies
- (2008) Amanda E. Sedgewick et al. BLOOD CELLS MOLECULES AND DISEASES
- Hydroxyurea in sickle cell disease—A study of clinico-pharmacological efficacy in the Indian haplotype
- (2008) K ITALIA et al. BLOOD CELLS MOLECULES AND DISEASES
- Fetal haemoglobin response to hydroxycarbamide treatment and sar1a promoter polymorphisms in sickle cell anaemia
- (2008) Chutima Kumkhaek et al. BRITISH JOURNAL OF HAEMATOLOGY
- Trends in Pediatric Sickle Cell Disease-Related Mortality in the United States, 1983-2002
- (2008) Emad Yanni et al. JOURNAL OF PEDIATRICS
- Hydroxyurea for the Treatment of Sickle Cell Anemia
- (2008) Orah S. Platt NEW ENGLAND JOURNAL OF MEDICINE
- A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia
- (2008) Courtney D. Thornburg et al. PEDIATRIC BLOOD & CANCER
- Hydroxyurea for Sickle Cell Disease: A Systematic Review for Efficacy and Toxicity in Children
- (2008) J. J. Strouse et al. PEDIATRICS
- DNA polymorphisms at the BCL11A, HBS1L-MYB, and -globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease
- (2008) G. Lettre et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now